Certainly in settings where high levels of IGF1 secretion are desired, such as in the treatment of myocardial infarction (Bagno et al., 2016), the use of MACS-derived ASC may be more beneficial compared to cultured-derived ASC. This evidence concerns the gene IGF1 and myocardial infarction.